BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 19, 2007
View Archived Issues
University of Buffalo awarded NIH grant for tinnitus research / News in Context
Read More
IMP-321, an immunopotentiator, activates human effector cytotoxic cells
Read More
QX-314 blocks nociception via TRPV1-mediated cell entry
Read More
Vitae and Boehringer Ingelheim to codevelop 11beta-HSD1 inhibitors
Read More
Cosmo and Ferring enter licensing agreement for Budesonide MMX
Read More
Drug candidate identified in COPD bronchodilator collaboration
Read More
Patient enrollment begins in phase III Zyflo trial for COPD
Read More
Abraxis and FDA reach agreement through SPA for phase III Abraxane trial
Read More
Physician's IND approved for Coramsine in U.S.
Read More
Orphan drug designation granted to KNS-760704
Read More
Lovaxin C safe for use in cervical cancer
Read More
Xanodyne receives license to XP-21510 for menorrhagia
Read More
Biovest seeks early approval for BiovaxID
Read More
Novel CCR2 antagonist shows in vivo efficacy in models of chronic inflammation
Read More
Positive phase IIa results reported for Locteron in hepatitis C
Read More
Forest and Gedeon report results from cariprazine phase II trial for schizophrenia
Read More
Elvucitabine shows potent anti-HIV activity in phase II
Read More
Novel selective D3 antagonist from GSK
Read More
CHMP issues negative opinion for extended Zavesca indication: Niemann Pick disease
Read More
Viracept license in Europe reinstated by EC
Read More
Recent Epix patent imparts new agents for preventing transplant rejection
Read More
Novartis Pharma seeks approval of Lucentis in Japan
Read More
FDA approves expanded labeling for Merck & Co.'s Januvia
Read More
Pfizer to cease sales of Exubera
Read More
New therapeutic options for cancer imparted in recent patents
Read More
European CHMP issues positive opinion for Atripla in HIV/AIDS; Health Canada gives its approval
Read More
Efficacy, tolerability of tapentadol immediate release assessed in acute pain following bunionectomy
Read More